Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Trade Name
Risk Category
  • Positive evidence of human fetal risk exists.
  • Potential benefits may warrant use of the drug in pregnant women despite potential risks (e.g. life threatening situations or serious illness).
The risk category is C in the first trimester.
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

  • Angiotensin-1 Converting enzyme inhibitor for treatment of hypertension.
  • Fetal Risk
    Fetal Risk
  • Use of the drug in the last two trimesters of pregnancy can cause fetal renal damage, facial and cranial malformations.
  • Causes reduced birth weight, anuria in the neonates.
  • Impaired fetal and renal function caused by the drug leads to oligohydramnios with subsequent fetal lung hypoplasia.
  • Breast Feeding
    Breast Feeding
  • Unknown excretion in breast milk.
  • Problems have not been documented.
  • Other Trade Names
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        Your Friend
     3   +   1    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Month Day Year